financetom
Business
financetom
/
Business
/
Stitch Fix Stock Falls After Q4 Results: Here's Why (CORRECTION)
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Stitch Fix Stock Falls After Q4 Results: Here's Why (CORRECTION)
Sep 24, 2024 7:21 PM

Editor’s Note: A correction was made to the fourth quarter revenue.

Stitch Fix, Inc. ( SFIX ) shares are trading lower after the company reported its fourth-quarter financial results after Tuesday's closing bell. Here's a look at the details from the report. 

The Details: Stitch Fix ( SFIX ) reported quarterly losses of 29 cents per share, which missed the analyst consensus estimate for losses of 19 cents. Quarterly revenue of $319.6 million beat the analyst consensus estimate of $318.5 million and is a 12.4% decrease year-over-year.

“We are executing our transformation strategy with discipline and, during the fourth quarter, we delivered results at the high end of our guidance on both the top and bottom line,” said Matt Baer, CEO of Stitch Fix ( SFIX ).

“I am proud of the Stitch Fix ( SFIX ) team’s efforts this past fiscal year and encouraged by the progress we have already made to strengthen the foundation of our business and reimagine our client experience. While there is a lot of work still to do, I am confident we are on the right path to continue to improve the trajectory of our business which includes returning to revenue growth by the end of FY26,” Baer added.

Read Next: What’s Going On With Intel Stock?

Outlook: Stitch Fix ( SFIX ) sees first-quarter revenue in a range of $303 million to $310 million and fiscal year 2025 revenue in a range of $1.11 billion to $1.16 billion.

SFIX Price Action: According to Benzinga Pro, Stitch Fix ( SFIX ) shares are down 19.15% after-hours at $3.07 at the time of publication Tuesday. 

Read Also:

Snowflake Stock Dips On Offering After-Hours: What To Know

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FERM FOOD Acquires Orkla’s Former Site and Scales Up: Up to 20,000 Tonnes of Fermented Ingredients Per Year
FERM FOOD Acquires Orkla’s Former Site and Scales Up: Up to 20,000 Tonnes of Fermented Ingredients Per Year
Mar 10, 2026
BÆKKE, Denmark--(BUSINESS WIRE)-- Danish ingredient producer FERM FOOD is acquiring Orkla’s former manufacturing site in Skovlund, Denmark, effective 1 April 2026. The acquisition provides new production facilities to expand the output of fermented plant-based ingredients for the food industry — driven by export demand that has emerged faster than expected. This press release features multimedia. View the full release here:...
ZIM Integrated Shipping Services Stock Surges: What's Driving The Rally?
ZIM Integrated Shipping Services Stock Surges: What's Driving The Rally?
Mar 10, 2026
ZIM Integrated Shipping Services Ltd ( ZIM ) shares are moving higher in extended trading on Monday after the company provided an update on an ongoing strategic review. ZIM Integrated Shipping stock is gaining positive traction. Why is ZIM stock advancing? What To Know: ZIM Integrated Shipping said it received multiple competitive proposals from strategic parties to acquire all outstanding shares of...
BRIEF-Taarifa Said On 10 March That It Has Informed National Media Group That It Does Not Intend To Make A Takeover Offer For NMG
BRIEF-Taarifa Said On 10 March That It Has Informed National Media Group That It Does Not Intend To Make A Takeover Offer For NMG
Mar 10, 2026
March 11 (Reuters) - Nation Media Group PLC: * TAARIFA LTD: ON 10TH MARCH, CO TOLD ITS INTENTION TO BOARD OF DIRECTORS OF NATIONAL MEDIA GROUP TO NOT MAKE A TAKE-OVER OFFER IN RESPECT OF NMG Source text: Further company coverage: ...
Fulgent Genetics to Acquire Bako Diagnostics and StrataDx for $55.5 Million
Fulgent Genetics to Acquire Bako Diagnostics and StrataDx for $55.5 Million
Mar 10, 2026
04:44 PM EST, 12/22/2025 (MT Newswires) -- Fulgent Genetics ( FLGT ) said late Monday that it will acquire Bako Diagnostics and StrataDx for $55.5 million, broadening its lab services platform and national reach. The acquisitions add anatomic pathology, proprietary PCR tests, and a national client base to Fulgen as Bako and StrataDx are CLIA certified and CAP accredited, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved